Literature DB >> 26278323

Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder.

Sean Bennett1, E Celia Marginean2, Melanie Paquin-Gobeil1, Jason Wasserman2, Joel Weaver1, Richard Mimeault1, Fady K Balaa1, Guillaume Martel1,3.   

Abstract

BACKGROUND: Intraductal papillary neoplasms of the biliary tract (IPNB) and intracholecystic papillary neoplasms (ICPN) are rare tumours characterized by intraluminal papillary growth that can be associated with invasive carcinoma. Their natural history remains poorly understood. This study examines clinicopathological features and outcomes.
METHODS: Patients who underwent surgery for IPNB/ICPN (2008-2014) were identified. Descriptive statistics and survival data were generated.
RESULTS: Of 23 patients with IPNB/ICPN, 10 were male, and the mean age was 68 years. The most common presentations were abdominal pain (n = 10) and jaundice (n = 9). Tumour locations were: intrahepatic (n = 5), hilar (n = 3), the extrahepatic bile duct (n = 8) and the gallbladder (n = 7). Invasive cancer was found in 20/23 patients. Epithelial subtypes included pancreatobiliary (n = 15), intestinal (n = 7) and gastric (n = 1). The median follow-up was 30 months. The 5-year overall (OS) and disease-free survivals (DFS) were 51% and 57%, respectively. Decreased OS (P = 0.09) and DFS (P = 0.05) were seen in patients with tumours expressing MUC1 on immunohistochemistry (IHC).
CONCLUSION: IPNB/ICPN are rare precursor lesions that can affect the entire biliary epithelium. At pathology, the majority of patients have invasive carcinoma, thus warranting a radical resection. Patients with tumours expressing MUC1 appear to have worse OS and DFSs.
© 2015 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26278323      PMCID: PMC4557656          DOI: 10.1111/hpb.12460

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  24 in total

1.  The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population.

Authors:  Jian Yang; Wentao Wang; Lunan Yan
Journal:  Dig Liver Dis       Date:  2011-09-17       Impact factor: 4.088

2.  Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.

Authors:  Yoh Zen; Motoko Sasaki; Takahiko Fujii; Tse-Ching Chen; Miin-Fu Chen; Ta-Sen Yeh; Yi-Yin Jan; Shiu-Feng Huang; Yuji Nimura; Yasuni Nakanuma
Journal:  J Hepatol       Date:  2005-12-05       Impact factor: 25.083

3.  Tubulopapillary adenoma of the gallbladder accompanied by bile duct tumor thrombus.

Authors:  Kentaroh Yamamoto; Fumio Yamamoto; Atsuhiro Maeda; Hirotsune Igimi; Mami Yamamoto; Ryosuke Yamaguchi; Yuichi Yamashita
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

4.  Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?

Authors:  Flavio G Rocha; Hwajeong Lee; Nora Katabi; Ronald P DeMatteo; Yuman Fong; Michael I D'Angelica; Peter J Allen; David S Klimstra; William R Jarnagin
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

5.  Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.

Authors:  Volkan Adsay; Kee-Taek Jang; Juan Carlos Roa; Nevra Dursun; Nobuyuki Ohike; Pelin Bagci; Olca Basturk; Sudeshna Bandyopadhyay; Jeanette D Cheng; Juan M Sarmiento; Oscar Tapia Escalona; Michael Goodman; So Yeon Kong; Paul Terry
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

6.  Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.

Authors:  Geunyoung Jung; Kwang-Min Park; Seung Soo Lee; Eunsil Yu; Seung-Mo Hong; Jihun Kim
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

7.  Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria.

Authors:  Yoh Zen; N Volkan Adsay; Krystof Bardadin; Romano Colombari; Linda Ferrell; Hironori Haga; Seung-Mo Hong; Prodromos Hytiroglou; Günter Klöppel; Gregory Y Lauwers; Dirk J van Leeuwen; Kenji Notohara; Kiyoko Oshima; Alberto Quaglia; Motoko Sasaki; Fausto Sessa; Arief Suriawinata; Wilson Tsui; Yutaka Atomi; Yasuni Nakanuma
Journal:  Mod Pathol       Date:  2007-04-13       Impact factor: 7.842

8.  Intraductal papillary neoplasia of the liver associated with hepatolithiasis.

Authors:  T C Chen; Y Nakanuma; Y Zen; M F Chen; Y Y Jan; T S Yeh; C T Chiu; T T Kuo; J Kamiya; K Oda; M Hamaguchi; Y Ohno; L L Hsieh; Y Nimura
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

9.  Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.

Authors:  Sin Young Park; Sang Jae Roh; Yo Na Kim; Sung Zoo Kim; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

10.  A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.

Authors:  N Minagawa; N Sato; Y Mori; T Tamura; A Higure; K Yamaguchi
Journal:  Eur J Surg Oncol       Date:  2013-03-15       Impact factor: 4.424

View more
  8 in total

1.  Intracholecystic papillary-tubular neoplasm in a patient with choledochal cyst: a link between choledochal cyst and gallbladder cancer?

Authors:  Adamantios Michalinos; Parakevi Alexandrou; Alexandros Papalambros; Dimitrios Oikonomou; Stratigoula Sakellariou; Evangelia Baliou; Andreas Alexandrou; Dimitrios Schizas; Evangelos Felekouras
Journal:  World J Surg Oncol       Date:  2016-08-02       Impact factor: 2.754

2.  A case report of intracholecystic papillary neoplasm of the gallbladder resembling a submucosal tumor.

Authors:  Ryo Muranushi; Hideyuki Saito; Asuka Matsumoto; Toshihide Kato; Naritaka Tanaka; Kenji Nakazato; Nobuhiro Morinaga; Yoshinori Shitara; Masatoshi Ishizaki; Takatomo Yoshida; Shinichi Aishima; Ken Shirabe
Journal:  Surg Case Rep       Date:  2018-09-27

3.  Progression to invasive cancer after snare polypectomy of intracholecystic papillary neoplasms during gallbladder stone removal by percutaneous transhepatic choledochoscopy: a case report.

Authors:  Chi Hyuk Oh; Seok Ho Dong
Journal:  BMC Gastroenterol       Date:  2020-11-30       Impact factor: 3.067

4.  Low-Grade Dysplastic Intracholecystic Papillary Neoplasia: A Case Report.

Authors:  Ana Logrado; Júlio Constantino; Carlos Daniel; Jorge Pereira; Maria Teresa Carvalho; Carlos Casimiro
Journal:  Am J Case Rep       Date:  2021-03-03

5.  Intracholecystic Papillary Neoplasm Localized to the Cystic Duct: A Case Report.

Authors:  Koichi Oishi; Masahiro Ikeda; Kazuhiro Toyota; Koichi Mandai; Tadateru Takahashi
Journal:  Case Rep Gastroenterol       Date:  2022-02-14

6.  Curative intent radical cholecystectomy followed by hyperthermic intraperitoneal chemotherapy in ruptured intraductal papillary neoplasm of gallbladder with invasive carcinoma.

Authors:  Gyeonggyu Choi; Seokwon Jang; Munseok Choi; Seungyoon Yang; Chunggeun Lee; Chang Moo Kang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

7.  Utility of Endoscopic Retrograde Cholangiopancreatography in the Treatment of Intraductal Papillary Neoplasm of the Bile Duct.

Authors:  Nicolas Patel; Adam Goodman
Journal:  ACG Case Rep J       Date:  2019-07-10

Review 8.  Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas.

Authors:  Piera Zaccari; Vincenzo Cardinale; Carola Severi; Federica Pedica; Guido Carpino; Eugenio Gaudio; Claudio Doglioni; Maria Chiara Petrone; Domenico Alvaro; Paolo Giorgio Arcidiacono; Gabriele Capurso
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.